Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)-Reference-Cited by-同舟云学术

Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)

Published:2017-12 Issue:12 Volume:112 Page:838-843
ISSN:1678-8060
Container-title:Memórias do Instituto Oswaldo Cruz
language:
Short-container-title:Mem. Inst. Oswaldo Cruz

Author:

Brahim Lucia Regina¹,Valete-Rosalino Cláudia Maria²,Antônio Liliane de Fátima³,Pimentel Maria Inês Fernandes⁴,Lyra Marcelo Rosandiski³,Paes Luiz Eduardo de Carvalho¹,Costa Ananda Dutra da³,Vieira Iracema Forni³,Dias Cristina Maria Giordano⁵,Duque Maria Cristina de Oliveira⁶,Marzochi Mauro Celio de Almeida³,Schubach Armando de Oliveira³

Affiliation:

1. Fundação Oswaldo Cruz-Fiocruz, Brasil; Fundação Oswaldo Cruz-Fiocruz, Brasil

2. Fundação Oswaldo Cruz-Fiocruz, Brasil; Universidade Federal do Rio de Janeiro, Brasil

3. Fundação Oswaldo Cruz-Fiocruz, Brasil

4. Fundação Oswaldo Cruz-Fiocruz, Brasil; Secretaria de Estado de Saúde do Rio de Janeiro, Brasil

5. Secretaria de Estado de Saúde do Rio de Janeiro, Brasil

6. Fundação Oswaldo Cruz-Fiocruz, Brasil; Secretaria Municipal de Saúde de Timóteo, Brasil

Publisher

FapUNIFESP (SciELO)

Subject

Microbiology (medical)

Link

http://www.scielo.br/pdf/mioc/v112n12/0074-0276-mioc-112-12-0838.pdf

Reference29 articles.

1. Montenegro skin test and age of skin lesion as predictors of treatment failure in cutaneous leishmaniasis;Antônio LF;Rev Inst Med Trop São Paulo,2014

2. Endemic tegumentary leishmaniasis in Brazil: correlation between level of endemicity and number of cases of mucosal disease;Bedoya-Pacheco SJ;Am J Trop Med Hyg,2011

3. Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis;Blum J;Int Health,2012

4. Leishmanioses do Continente Americano;Conceição-Silva F,2014

5. Oral manifestations in the American tegumentary leishmaniasis;Costa DCS;PloS ONE,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of intralesional treatment in american tegumentary leishmaniasis in the amazon region: results and perspectives;Cuadernos de Educación y Desarrollo;2024-03-12

2. Platelet-Derived Microvesicles Contribute to the Pathophysiogenesis of Human Cutaneous Leishmaniasis: A Nano-Flow Cytometric Approach in Plasma Samples from Patients before and under Antimonial Treatment;Microorganisms;2024-03-06

3. Is There Any Difference in the In Situ Immune Response in Active Localized Cutaneous Leishmaniasis That Respond Well or Poorly to Meglumine Antimoniate Treatment or Spontaneously Heal?;Microorganisms;2023-06-22

4. Intralesional Antimonial Drug Treatment for Leishmania braziliensis Cutaneous Leishmaniasis: The Knowns and the Unknowns;Clinical Infectious Diseases;2023-04-26

5. A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil;Clinical Infectious Diseases;2023-04-26